Jung, J., Lee, J. S., Dickson, M. A., Schwartz, G. K., Cesne, A. L., Varga, A., . . . Watters, J. (2016). TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma. Nature Portfolio.
Style de citation Chicago (17e éd.)Jung, Joonil, et al. TP53 Mutations Emerge with HDM2 Inhibitor SAR405838 Treatment in De-differentiated Liposarcoma. Nature Portfolio, 2016.
Style de citation MLA (8e éd.)Jung, Joonil, et al. TP53 Mutations Emerge with HDM2 Inhibitor SAR405838 Treatment in De-differentiated Liposarcoma. Nature Portfolio, 2016.
Attention : ces citations peuvent ne pas être correctes à 100%.